Medicare Enrolled
Dr. Richard Lam, M.D.
Optician · Marina Del Rey, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lam
Dr. Richard Lam is an optician specialist in Marina Del Rey, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lam performed 15,632 Medicare services across 4,835 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lam received a total of $7,084 from 41 pharmaceutical and/or device companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in CA
$7,084 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,632
Medicare services
Top 6% in CA for optician
4,835
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~823 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,500 | $18 | $28 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,301 | $147 | $325 |
| PSA test (prostate cancer screening) | 704 | $18 | $60 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
682 | $8 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
677 | $8 | $15 |
| Prostatic acid phosphatase level test A blood test that measures the level of prostatic acid phosphatase, an enzyme produced by the prostate gland. |
676 | $9 | $35 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
537 | $25 | $90 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
492 | $21 | $60 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
306 | $9 | $45 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
280 | $27 | $60 |
| Follicle stimulating hormone (FSH) level A blood test to measure the level of follicle stimulating hormone, a reproductive hormone. |
280 | $18 | $75 |
| Luteinizing hormone level test A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function. |
280 | $18 | $75 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 228 | $137 | $750 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $104 | $225 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
194 | $16 | $55 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
193 | $9 | $25 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
193 | $17 | $50 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
179 | $123 | $249 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
179 | $244 | $650 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
101 | $12 | $50 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
94 | $30 | $145 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
80 | $3 | $15 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
69 | $8 | $24 |
| Liver function blood test panel | 69 | $8 | $22 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
31 | $13 | $85 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
28 | $15 | $47 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
27 | $15 | $42 |
| New patient office visit, complex (60-74 min) | 21 | $180 | $1,076 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
19 | $27 | $200 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
14 | $7 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,084
Total received (2018-2024)
Avg $1,012/year across 7 years
Top 18% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,680 (94.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$404 (5.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,632
2023
$1,123
2022
$1,181
2021
$634
2020
$544
2019
$644
2018
$1,325
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$267
PFIZER INC.
$184
Janssen Biotech, Inc.
$179
Bayer Healthcare Pharmaceuticals Inc.
$168
Dendreon Pharmaceuticals LLC
$151
Myriad Genetic Laboratories, Inc.
$133
Sumitomo Pharma America, Inc.
$89
Astellas Pharma US Inc
$83
ABBVIE INC.
$83
PROGENICS PHARMACEUTICALS, INC.
$81
Novartis Pharmaceuticals Corporation
$56
Merck Sharp & Dohme LLC
$44
SUN PHARMACEUTICAL INDUSTRIES INC.
$44
Exact Sciences Corporation
$25
ACCORD HEALTHCARE, INC.
$23
Coherus Biosciences Inc.
$22
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,072
Amgen Inc.
$745
PFIZER INC.
$676
Dendreon Pharmaceuticals LLC
$571
Astellas Pharma US Inc
$519
AstraZeneca Pharmaceuticals LP
$433
Bayer HealthCare Pharmaceuticals Inc.
$382
Myriad Genetic Laboratories, Inc.
$337
Bayer Healthcare Pharmaceuticals Inc.
$304
Boehringer Ingelheim Pharmaceuticals, Inc.
$290
Blue Earth Diagnostics Limited
$187
Sumitomo Pharma America, Inc.
$165
Novartis Pharmaceuticals Corporation
$145
Merck Sharp & Dohme LLC
$123
Genentech USA, Inc.
$123
ABBVIE INC.
$83
PROGENICS PHARMACEUTICALS, INC.
$81
GENZYME CORPORATION
$68
MEDIVATION FIELD SOLUTIONS LLC
$64
Foundation Medicine, Inc.
$63
Endo Pharmaceuticals Inc.
$62
Merck Sharp & Dohme Corporation
$54
Coherus Biosciences Inc.
$54
ACCORD HEALTHCARE, INC.
$47
Exact Sciences Corporation
$45
Mylan Institutional Inc.
$44
SUN PHARMACEUTICAL INDUSTRIES INC.
$44
Myovant Sciences Inc.
$43
AbbVie, Inc.
$41
Sun Pharmaceutical Industries Inc.
$30
Ferring Pharmaceuticals Inc.
$23
AbbVie Inc.
$22
Spectrum Pharmaceuticals Inc.
$20
Avadel Specialty Pharmaceuticals, LLC
$19
AKRIMAX PHARMACEUTICALS, LLC
$17
Mannkind Corporation
$16
IDORSIA PHARMACEUTICALS US INC
$16
Regeneron Healthcare Solutions, Inc.
$16
Augmenix, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$11
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AKYNZEO · AVEED · Aranesp · Axumin · BRACANALYSIS CDX · CAMCEVI · Cologuard Collection Kit · ENTRESTO · ERLEADA · EVENITY · Erleada · FIRMAGON · FOUNDATIONONE LIQUID CDX · Fulphila · INLYTA · JARDIANCE · JEVTANA · KEYTRUDA · LIBTAYO · LUPRON DEPOT · LYNPARZA · Lucentis · Lupron · Lupron Depot · MVASI · MYRBETRIQ · MYRISK · Neulasta · Noctiva · Nplate · Nubeqa · ORGOVYX · PAXLOVID · PIQRAY · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · QUVIVIQ · ROLVEDON · SEGLENTIS · SpaceOAR · Stendra · TALZENNA · TESTOPEL · Udenyca · VESICARE · Veozah · XGEVA · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,509
Per 100K population
15.3
County median income
$87,760
Nearest hospital
CEDAR-SINAI MARINA DEL REY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lam is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lam experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lam performed 7,500 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lam receive payments from pharmaceutical companies?
Yes. Dr. Lam received a total of $7,084 from 41 companies across 336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lam's costs compare to other opticians in Marina Del Rey?
Dr. Lam's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Marina Del Rey
Browse opticians in Marina Del Rey ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology